Voyageur Pharma reports 99.8% iodine purity in Mueller extraction process tests

• Voyageur Pharmaceuticals reported lab results for its patent-pending Mueller process, producing iodine at 99.8% purity with overall recovery above 90%.
• Houston lab work used Anadarko and Permian Basin produced water, demonstrating continuous operation with clean brine suitable for disposal or reinjection.
• A mobile pilot unit sized for 80,000 liters per day is built; field testing is set to start in coming weeks, with operations planned for September 2026.
• Preliminary design work outlined a 200 metric-ton-per-year modular plant concept, targeting multiple disposal sites with a central finishing hub.
• The program supports a planned North American iodine supply chain; long-term goal targets up to 1,000 metric tons per year of iodine capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyageur Pharmaceuticals Ltd. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202608100700TNWSWRCACNPR_____1B2aFdvzP) on August 10, 2026, and is solely responsible for the information contained therein.